Upcoming Live Events
Wed 6:30 PM EDT
Recognizing Uncontrolled Asthma Is Only the First Step
A goal of asthma treatment is to achieve and maintain asthma control. However, uncontrolled asthma remains common and often goes unrecognized by patients and...
Wed 6:30 PM EDT
REPLACE: (Riociguat rEplacing PDE5i therapy evaluated Against Continued PDE5i therapy): A Look at Phase IV Study Data
Wed 6:30 PM EDT
The Role of OFEV® (nintedanib) capsules: A Treatment Journey
Join Dr. Shambhu Aryal as he reviews background information followed by an overview of the OFEV pivotal safety and efficacy data. This presentation is made on behalf...
Mon 12:00 PM EDT
COVID-19: From Early Treatment to Inpatient Management
This Innovation Theatre is intended to educate attendees on the current management of COVID-19 patients in the outpatient and critical care setting. Attendees will...
Mon 12:00 PM EDT
Consider Giving Your Patients What They Prefer: How Should Patient Preferences Inform Inhaler Decisions in COPD?
Boehringer Ingelheim is pleased to bring you a stimulating discussion featuring experts, Donald Mahler, MD and Jill Ohar, MD.
Past Live Events
Tue 6:30 PM EDT
Impact of Robotic-Assisted Bronchoscopy
MONARCH® Platform Programs In An Academic & Community Setting. Drs. D. Kyle Hogarth and Susan Garwood share their firsthand experience using MONARCH®, the first...
Wed 6:30 PM EDT
Disrupting the Lung Cancer Care Continuum with Novel Genomic Tests from Diagnosis to Treatment Management
Speakers will discuss the gaps in the lung cancer diagnosis and care continuum and the transformative role of novel genomic tests, such as a non-invasive nasal swab...
Wed 6:30 PM EDT
Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical Care
This presentation will provide an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty...
Wed 6:30 PM EDT
TSLP in Asthma: Examining the Evidence
There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as two experts explore the role of a key epithelial cytokine,...
Mon 12:00 PM EST
Clinical Evidence for the Selection of Triple Therapy for the Management of Adults With Asthma or COPD
Join Dr. Nathanael Brady as he explores recent clinical evidence supporting the use of triple therapy for the maintenance treatment of adult patients with Asthma or...
Wed 6:30 PM EST
Functional Lung Imaging: Translational Medicine and Clinical Applications
Understanding of the determinants of ventilation defects and ventilation heterogeneity may lead to more efficacious treatments for acute and chronic lungs diseases and...
Wed 3:30 PM PST
What Was Old Is New Again. A Novel, More Bioavailable Antifungal
Join Shyam Subramanian, MD FCCP, on February 17, 2021 at 6:30 pm as he discusses the diagnosis and management of systemic fungal infections and shares how advanced...
Mon 9:00 AM PST
Nasal High Flow Before, During, and After COVID-19. What Comes Next?
This webinar will explore the mechanism of action of Nasal High Flow and the clinical evidence for use before and during the COVID-19 pandemic. Evidence for the use of...
Wed 6:30 PM EST
The COVID-19 Pandemic and A Treatment Approach for Hospitalized Patients
This program will cover the epidemiology of the current COVID-19 pandemic and show where demographic disparities exist. Information on the clinical trials, efficacy...
Mon 6:30 PM EST
Underlying Inflammatory Mechanisms: Nasal Polyposis and Airway Comorbidities
An informative, non-CME, virtual disease state presentation focusing on nasal polyposis and airway comorbidities. This presentation will familiarize viewers with the...
Tue 6:30 PM EST
Interstitial Lung Diseases: An Overview of Progression and Radiological Features
Join Drs. Gregory Cosgrove and Jonathan Chung as they discuss the HRCT features and patterns associated with a progressive phenotype in patients with chronic fibrosing...
Mon 6:30 PM EST
REPLACE (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy): A look at Phase IV Study Data
This virtual learning session will review the clinical data from a recent Phase IV study looking at a treatment paradigm in the management of adult patients with PAH
Wed 6:30 PM EST
A Potential Therapy for Rebalancing BMPR2: A New Direction in PAH
Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.
Mon 6:30 PM EST
Hot Topics in ILD Diagnosis: MDD, Genomics and PF ILD
This interactive session covers the key elements of an MDD, the role of the Envisia genomic classifier, and the identification of progressive fibrosing ILD.
Tue 6:30 PM EST
Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype
This program will provide an overview on chronic fibrosing interstitial lung diseases (ILDs), with specific examples of those with progressive phenotypes. Expert...
Thu 6:30 PM EDT
The Role of Eosinophils and Their Potential Heterogeneity in Airway Disease
Eosinophils are increasingly being recognized as important in the pathophysiology of various airway diseases and an important cell type in disease endotypes. This...
Fri 12:00 PM EDT
Nebulization in the COVID-19 Era: Evidence-Based Review
Nebulization safety in the COVID-19 era has been challenged due to concerns regarding transmissibility of the virus via nebulizer. Join International expert Rajiv...
Thu 6:30 PM EDT
A Path to Asthma Control
A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma
Tue 6:30 PM EDT
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
This expert-led event will include a review and discussion of clinical and real-world data evaluating a biologic treatment to help reduce exacerbations and maintenance...
Thu 6:30 PM EDT
Management of Adults With Asthma or COPD With Inhaled Maintenance Treatment Options
Are you up to date on the newest developments in Asthma and COPD maintenance treatment options? Join Dr. Ravi Kalhan review the latest clinical evidence supporting the...
Tue 6:30 PM EDT
Sounding the Alarm: The Role of TSLP Across the Spectrum of Asthma Inflammation
There’s a new way to think about asthma and it starts at the top of the inflammatory cascade. Join us as an expert explores the role of a key epithelial cytokine,...
Tue 12:00 PM EDT
COPD Management in the time of COVID-19 & New Real World Data on Inhaler Choice
Has COVID-19 impacted the way you treat your COPD patients?
Thu 6:30 PM EDT
The Current State of OFEV® (nintedanib): A Treatment Journey
The program will review background information followed by the most up-to-date data supporting the efficacy and safety of OFEV. The presentation is sponsored by...
Thu 6:30 PM EDT
ACCURACY IS EVERYTHING: RECENT CLINICAL EVIDENCE IN NAVIGATION
A static image can make nodule biopsies using lung navigation challenging. You need confidence throughout the procedure to know you are on target. Learn about the...
Tue 6:30 PM EDT
Chronic Rhinosinusitis With Nasal Polyps: From Pathophysiology to Management
An informative, non-CME, disease state virtual presentation focusing on chronic rhinosinusitis with nasal polyps (CRSwNP).
Tue 6:30 PM EDT
A New Direction in PAH: A Potential Therapy for Rebalancing BMPR2 Signaling
Join us for a presentation focused on a new potential therapy that may change the course of PAH progression by rebalancing BMPR2 signaling.
Tue 6:30 PM EDT
Treatable traits approach towards COPD management for busy pulmonologists
With the GOLD 2020 strategy document, the focus on utilization of the treatable traits approach of symptoms and exacerbations for COPD management continues to gain...
Thu 4:00 PM EDT
Best Practices in Remote Patient Monitoring for the Respiratory Specialist
Respiratory Specialists are now rapidly adapting their models of care in light of COVID-19. What are the best practices for remote monitoring of respiratory patients?...